New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs

Peptides

Volumn 29, Issue 6, 2008, Pages 992-1003

  Čeřovský, Václav ^a   Slaninová, Jiřina ^a   Fučík, Vladimír ^a   Hulačová, Hana ^a   Borovičková, Lenka ^a   Ježek, Rudolf ^a   Bednárová, Lucie ^a  

^a INSTITUTE OF ORGANIC CHEMISTRY AND BIOCHEMISTRY   (Czech Republic)

Author keywords

Amphipathicity; Analogs; Antimicrobial peptides; Circular dichroism; Hemolytic activity; Mast cell degranulation; Wasp venom

Indexed keywords

DODECYL SULFATE SODIUM; HISTIDYLASPARAGINYLISOLEUCYLTRYPTOPHYLLYSYLSERYLISOLEUCYLPHENYL ALANYLGLUTAMYLLYSYLVALYLLYSYLASPARAGINYLLEUCYLVALINAMIDE; HISTIDYLISOLEUCYLASPARAGINYLPHENYLALANYLLEUCYLLYSYLLEUCYL GLYCYLLYSYLLYSYLISOLEUCYLLEUCYLGLYCYLALANYLLEUCINAMIDE; HISTIDYLISOLEUCYLASPARAGINYLSERYLLEUCYLLYSYLLEUCYLGLYCYLLYSYLLYSYL ISOLEUCYLLEUCYLGLYCYLALANYLLEUCINAMIDE; HISTIDYLISOLEUCYLASPARAGINYLTRYPTOPHYLLEUCYLARGINYLLEUCYL GLYCYLARGINYLARGINYLISOLEUCYLLEUCYLGLYCYLALANYLLEUCINAMIDE; HISTIDYLISOLEUCYLASPARAGINYLTRYPTOPHYLLEUCYLLYSYLLEUCYLGLYCYL LYSYLLYSYLISOLEUCYLLEUCYLGLYCYLALANYLISOLEUCINAMIDE; HISTIDYLISOLEUCYLASPARAGINYLTRYPTOPHYLLEUCYLLYSYLLEUCYLGLYCYL LYSYLLYSYLISOLEUCYLLEUCYLGLYCYLALANYLLEUCINAMIDE; HISTIDYLISOLEUCYLASPARAGINYLTRYPTOPHYLLEUCYLLYSYLLEUCYLGLYCYLLYSYL LYSYLLEUCYLLEUCYLSERYLALANYLLEUCINAMIDE; HISTIDYLISOLEUCYLASPARAGINYLTRYPTOPHYLLEUCYLLYSYLLEUCYLGLYCYLLYSYL LYSYLMETHIONYLMETHIONYLSERYLALANYLISOLEUCINAMIDE; HISTIDYLISOLEUCYLASPARAGINYLTRYPTOPHYLLEUCYLLYSYLLEUCYLGLYCYLLYSYL LYSYLMETHIONYLMETHIONYLSERYLALANYLLEUCINAMIDE; HISTIDYLISOLEUCYLASPARAGINYLTRYPTOPHYLLEUCYLLYSYLLEUCYLGLYCYLLYSYL LYSYLNORLEUCYLNORLEUCYLSERYLALANYLLEUCINAMIDE; HISTIDYLISOLEUCYLASPARAGINYLTRYPTOPHYLLYSYLLYSYLISOLEUCYLPHENYL ALANYLGLUTAMYLLYSYLVALYLSERYLASPARAGINYLLEUCYLVALINAMIDE; HISTIDYLISOLEUCYLASPARAGINYLTRYPTOPHYLLYSYLLYSYLISOLEUCYLPHENYL ALANYLGLUTAMYLSERYLVALYLLYSYLASPARAGINYLLEUCYLVALINAMIDE; HISTIDYLISOLEUCYLASPARAGINYLTRYPTOPHYLLYSYLLYSYLISOLEUCYLPHENYLALANYL GLUTAMINYLLYSYLVALYLLYSYLASPARAGINYLLEUCYLVALINAMIDE; HISTIDYLISOLEUCYLASPARAGINYLTRYPTOPHYLLYSYLLYSYLISOLEUCYLPHENYLALANYL GLUTAMYLLYSYLVALYLLYSYLASPARAGINYLLEUCYLVALINAMIDE; HISTIDYLISOLEUCYLASPARAGINYLTRYPTOPHYLLYSYLLYSYLISOLEUCYLPHENYLALANYL GLUTAMYLLYSYLVALYLLYSYLASPARTYLLEUCYLVALINAMIDE; HISTIDYLISOLEUCYLASPARAGINYLTRYPTOPHYLLYSYLLYSYLLEUCYL GLYCYLLYSYLLYSYLISOLEUCYLLEUCYLGLYCYLALANYLLEUCINAMIDE; HISTIDYLISOLEUCYLASPARAGINYLTRYPTOPHYLLYSYLSERYLISOLEUCYLPHENYL ALANYLGLUTAMYLLYSYLVALYLLYSYLASPARAGINYLLEUCYLVALINAMIDE; HISTIDYLISOLEUCYLASPARAGINYLTRYPTOPHYLSERYLLYSYLISOLEUCYLPHENYL ALANYLGLUTAMYLLYSYLVALYLLYSYLASPARAGINYLLEUCYLVALINAMIDE; HISTIDYLISOLEUCYLASPARAGINYLTRYPTOPHYLSERYLSERYLISOLEUCYLPHENYL ALANYLGLUTAMYLLYSYLVALYLLYSYLASPARAGINYLLEUCYLVALINAMIDE; HISTIDYLISOLEUCYLASPARAGINYLTRYPTOPHYLSERYLSERYLISOLEUCYLPHENYL ALANYLGLUTAMYLSERYLVALYLLYSYLASPARAGINYLLEUCYLVALINAMIDE; HISTIDYLISOLEUCYLASPARAGINYLTRYPTOPHYLSERYLSERYLISOLEUCYLPHENYL ALANYLGLUTAMYLSERYLVALYLSERYLASPARAGINYLLEUCYLVALINAMIDE; HISTIDYLISOLEUCYLASPARTYLTRYPTOPHYLLYSYLLYSYLISOLEUCYLPHENYLALANYL GLUTAMYLLYSYLVALYLLYSYLASPARAGINYLLEUCYLVALINAMIDE; HISTIDYLISOLEUCYLASPARTYLTRYPTOPHYLLYSYLLYSYLISOLEUCYLPHENYLALANYL GLUTAMYLLYSYLVALYLLYSYLASPARTYLLEUCYLVALINAMIDE; HISTIDYLSERYLASPARAGINYLTRYPTOPHYLLEUCYLLYSYLLEUCYLGLYCYLLYSYLLYSYL METHIONYLMETHIONYLSERYLALANYLLEUCINAMIDE; POLYPEPTIDE ANTIBIOTIC AGENT; TETRACYCLINE; TRIFLUOROETHANOL; UNINDEXED DRUG; WASP VENOM;

ACYLATION; ALPHA HELIX; AMINO ACID SUBSTITUTION; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANISOTROPY; ARTICLE; BACILLUS SUBTILIS; CARBOXY TERMINAL SEQUENCE; CIRCULAR DICHROISM; CONTROLLED STUDY; DEAMINATION; DRUG CONFORMATION; DRUG POTENCY; DRUG SYNTHESIS; ESCHERICHIA COLI; HEMOLYSIS; HYDROPHOBICITY; MAST CELL; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN CONFORMATION; PSEUDOMONAS AERUGINOSA; RAT; STAPHYLOCOCCUS AUREUS;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMALS; ANTI-BACTERIAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; BACILLUS SUBTILIS; CELL DEGRANULATION; ERYTHROCYTES; ESCHERICHIA COLI; HEMOLYSIS; HYDROPHOBICITY; INHIBITORY CONCENTRATION 50; MAST CELLS; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; PEPTIDES; PSEUDOMONAS AERUGINOSA; RATS; STAPHYLOCOCCUS AUREUS; WASP VENOMS; WASPS;

BACILLUS SUBTILIS; ESCHERICHIA COLI; MISCHOCYTTARUS PHTHISICUS; POLISTES DORSALIS; POLISTES MAJOR; POLISTINAE; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS;

EID: 43049086265     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2008.02.007     Document Type: Article

References (41)

1. Backlund B.-M., Wikander G., Peeters T., and Graslund A. Induction of secondary structure in the peptide hormone motilin by interaction with phospholipid vesicles. Biochim Biophys Acta 1190 (1994) 337-344
2. Bütner K., Blondelle S.E., Ostresh J.M., and Houghten R.A. Perturbation of peptide conformations induced in anisotropic environments. Biopolymers 32 (1992) 575-583
3. Čeřovský V., Pohl J., Alam N., Yang Z., and Attygalle A.B. Identification of three novel peptides isolated from the venom of the neotropical social wasp Polistes major major. J Pept Sci 13 (2007) 445-450
4. Conlon J.M., Al-Ghaferi N., Abraham B., and Leprince J. Strategies for transformation of naturally-occurring amphibian antimicrobial peptides into therapeutically valuable anti-infective agents. Methods 42 (2007) 349-357
5. Eisenberg D., Schwarz E., Komaromy M., and Wall R. Analysis of membrane and surface proteins sequences with the hydrophobic moment plot. J Mol Biol 179 (1984) 125-142
6. Fields G.B., and Noble R.L. Solid phase peptide synthesis utilizing 9-fluorenylmethoxycarbonyl amino acid. Int J Pept Protein Res 35 (1990) 161-214
7. Gomperts B.D., and Tatham P.E.R. Regulated exocytotic secretion from permeabilized cells. Methods Enzymol 219 (1992) 178-189
8. Hancock R.E.W., and Sahl H.-G. Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat Biotechnol 24 (2006) 1551-1557
9. Hirai Y., Yasuhara T., Yoshida H., Nakajima T., Fujino M., and Kitada C. A new mast cell degranulating peptide "mastoparan" in the venom of Vespula lewisii. Chem Pharm Bull 27 (1979) 1942-1944
10. Konno K., Rangel M., Oliveira J.S., dos Santos Cabrera M.P., Fontana R., Hirata I.Y., et al. Decoralin, a novel linear cationic a-helical peptide from the venom of the solitary eumenine wasps Oreumenes decoratus. Peptides 28 (2007) 2320-2327
11. Krchňák V., Wágner J., Šafář P., and Lebl M. Noninvasive continuous monitoring of solid-phase peptide synthesis by acid-base indicator. Collect Czech Chem Commun 53 (1988) 2542-2548
12. Kuhn-Nentwig L. Antimicrobial and cytolytic peptides of venomous arthropods. Cell Mol Life Sci 60 (2003) 2651-2668
13. Lequin O., Ladram A., Chabbert L., Bruston F., Convert O., Vanhoye D., et al. Dermaseptin S9, an alfa/helical antimicrobial peptide with a hydrophobic core and cationic termini. Biochemistry 45 (2006) 468-480
14. Mant C.T., Burke T.W.L., Black J.A., and Hodges R.S. Effect of peptide chain length on peptide retention behaviour in reversed-phase chromatography. J Chromatogr 458 (1988) 193-205
15. Mendes M.A., De Sousa B.M., Marques M.R., and Palma M.S. Structural and biological characterization of two novel peptides from the venom of the neotropical social wasp Agelaia pallipes palipes. Toxicon 44 (2004) 67-74
16. Mendes M.A., de Souza B.M., and Palma M.S. Structural and biological characterization of three novel mastoparans peptides from the venom of the neotropical social wasp Protopolybia exigua (Saussure). Toxicon 45 (2005) 101-106
17. Mor A., and Nicolas P. The NH2-terminal α-helical domain 1-18 of dermaseptin is responsible for antimicrobial activity. J Biol Chem 269 (1994) 1934-1939
18. Nakajima T. Pharmacological biochemistry of vespid venoms. In: Piek T. (Ed). Venoms of the hymenoptera: biochemical, pharmacological and behavioural aspects (1986), Academic Press, London 309-327
19. Nakajima T., Uzu S., Wakamatsu K., Saito K., Miyazawa T., Yasuhara T., et al. Amphiphilic peptides in wasp venom. Biopolymers 25 (1986) 115-121
20. Oren Z., and Shai Y. Selective lysis of bacteria but not mammalian cells by dia-stereoisomers of mellitin: structure function study. Biochemistry 36 (1997) 1826-1835
21. Oren Z., and Shai Y. Mode of action of linear amphipathic α-helical antimicrobial peptides. Biopolymers 47 (1998) 451-463
22. Park N.G., Yamato Y., Lee S., and Sugihara G. Interaction of mastoparan-B from venom of hornet in Taiwan with phospholipids bilayers and its antimicrobial activity. Biopolymers 36 (1995) 793-801
23. Pathak N., Salas-Auvert R., Ruche G., Janna M.-H., McCarthy D., and Harrison R.G. Comparison of the effect of hydrophobicity, amphiphilicity, and α-helicity on the activities of antimicrobial peptides. Proteins: Struct Funct Genet 22 (1995) 182-186
24. Rohl C.A., and Baldwin R.L. Deciphering rules of helix stability in peptides. Methods Enzymol 295 (1998) 1-26
25. Sader H.S., Fedler K.A., Rennie R.P., Stevens S., and Jones R.N. Omiganan pentahydrochloride (MBI 226), a topical 12-amino-acid cationic peptide: spectrum of antimicrobial activity and measurements of bactericidal activity. Antimicrob Agents Chemother 48 (2004) 3112-3118
26. dos Santos Cabrera M.P., de Souza B.M., Fontana R., Konno K., Palma M.S., de Azevedo Jr. W.F., et al. Conformation and lytic activity of eumenine mastoparan: a new antimicrobial peptide from wasp venom. J Pept Res 64 (2004) 95-103
27. Schiffer M., and Edmundson A.B. Use of helical wheels to represent the structures of proteins and to identify segments with helical potential. Biophys J 7 (1967) 121-135
28. Sforca M.L., Oyama Jr. S., Canduri F., Lorenzi C.C., Pertinhez T.A., Konno K., et al. How C-terminal carboxyamidation alters the biological activity of peptides from the venom of the eumenine solitary wasp. Biochemistry 43 (2004) 5608-5617
29. Skerlavaj B., Gennaro R., Bagella L., Merluzzi L., Risso A., and Zanetti M. Biological characterization of two novel cathelicidin-derived peptides and identification of structural requirements for their antimicrobial and cell lytic activities. J Biol Chem 271 (1996) 28375-28381
30. Simmaco M., Mignogna G., and Barra D. Antimicrobial peptides from amphibian skin: what do they tell us?. Biopolymers (Pept Sci) 47 (1998) 435-450
31. Souza B.M., Mendes M.A., Santos L.D., Marques M.R., César L.M.M., Almeida R.N.A., et al. Structural and functional characterization of two novel peptide toxins isolated from the venom of the social wasp Polybia paulista. Peptides 26 (2005) 2157-2164
32. Steiner A. Stinging behaviour of solitary wasps. In: Piek T. (Ed). Venoms of the hymenoptera: biochemical, pharmacological and behavioural aspects (1986), Academic Press, London 63-160
33. Toke O. Antimicrobial peptides: new candidates in the fight against bacterial infection. Biopolymers (Pept Sci) 80 (2005) 717-735
34. Tossi A., Sandri L., and Giangaspero A. Amphipathic, α-helical antimicrobial peptides. Biopolymers (Pept Sci) 55 (2000) 4-30
35. Turillazi S., Mastrobuoni G., Dani F.R., Moneti G., Pieraccini G., la Marca G., et al. Dominulin A and B: two new antimicrobial peptides identified on the cuticle and in the venom of the social paper wasp Polistes dominulus using MALDI-ToF, MALDI-ToF/ToF, and ESI-Ion trap. J Am Soc Mass Spectrom 17 (2006) 376-383
36. Waterhous D.V., and Johnson Jr. W.C. Importance of environment in determining secondary structure in proteins. Biochemistry 33 (1994) 2121-2128
37. Wieprecht T., Dathe M., Krause M., Beyermann M., Maloy W.L., MacDonnald D.L., et al. Modulation of membrane activity of amphipathic, antimicrobial peptides by slight modification of hydrophobic moment. FEBS Lett 417 (1997) 135-140
38. Yeaman M.R., and Yount N.Y. Mechanisms of antimicrobial peptide action and resistance. Pharm Rev 55 (2003) 27-55
39. Zhong L., and Johnson Jr. W.C. Environment affects amino acid preference for secondary structure. Proc Natl Acad Sci USA 89 (1992) 4462-4465
40. Zhu W.L., Hahm K.S., and Shin S.Y. Cathelicidin-derived Trp/Pro-rich antimicrobial peptides with lysine peptoid residue (Nlys): therapeutic index and plausible mode of action. J Pept Sci 13 (2007) 529-535
41. Zikou S., Koukkou A.-I., Mastora P., Sakarellos-Daitsiotis M., Sakarellos C., Drainas C., et al. Design and synthesis of cationic Aib-containing antimicrobial peptides: conformational and biological studies. J Pept Sci 13 (2007) 481-486